Publication | Closed Access

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial

UrologySingle-arm Phase 3BGenitourinary CancerMedicineClinical TrialsEarly AccessPharmacotherapyCancer TreatmentProstatic DiseaseOncologyConcomitant TherapiesMolecular Oncology